| 149 |
RENOVATE Trial: DOAC vs. Warfarin for Mechanical Aortic Valve Prosthesis |
Joon Bum Kim |
Apr. 17. 25 |
| 148 |
Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry |
Hansu Park |
Apr. 17. 25 |
| 147 |
Current Status of Tricuspid Valve Interventions in Asia Pacific Region |
Shih-Hsien Sung |
Apr. 17. 25 |
| 146 |
A Novel Vertical Spacer for Tricuspid Regurgitation: Early Experiences of the Pivot-TR System |
Joo-Yong Hahn |
Apr. 17. 25 |
| 145 |
Novel Transcatheter Tricuspid Valve (CroiValve): Data From FIM Study |
Wojciech Wojakowski |
Apr. 17. 25 |
| 144 |
TTEER or TTVR : How to Decide? |
Cheung Chi Simon Lam |
Apr. 17. 25 |
| 143 |
Transcatheter Mitral Valve Intervention: What Is Next? |
Juan F. Granada |
Apr. 17. 25 |
| 142 |
Prediction and Prevention of LVOT Obstruction During TMVR |
David Joel Cohen |
Apr. 17. 25 |
| 141 |
How to Deal With Patients With Severe MR and Severe TR? |
Yohei Ohno |
Apr. 17. 25 |
| 140 |
Streamlining Procedural Workflow in Mitral TEER Using Echo and Fluoro: Tips and Tricks |
Gilbert H. L. Tang |
Apr. 17. 25 |
